Cao Yong Tong
China-Japan Friendship Hospital · Laboratory Department · Beijing
1985 8 --1991 7,1993 8 --1996 7,1998 4 --2002 1,1997 4 --1998 4,2010 10 --2010 11,2011 9 --2011 10:1991, 、 、 、.: 、 、 “863”, SCI 40. ( 1 ) FTO m6A LINC00921 ( 2 ) Lp-PLA2/LPC ( 3 ) ( 4 ) “863” ( 5 ) “863” ( 6 ) A、E 、 ( 7 ): SCI 40, 10. [ 1 ]Li,LinZhang #;Han,ChengWu;Yu,XueYing;Shen,Jun;Cao,YongTong *.TargetingAraC-ResistantAcuteMyeloidLeukemiabyDualInhibitionofCDK9andBcl-2:ASystematicReviewandMeta-Analysis[J].JOURNALOFHEALTHCAREENGINEERING,2022,2022. [ 2 ]Liu,Yi #;Kong,XiaoMu;Jiang,YongWei;Zhao,MeiMei;Gao,Peng;Cong,Xiao;Cao,YongTong *;Ma,Liang *.AssociationofAGTR1A1166CandCYP2C9*3GenePolymorphismswiththeAntihypertensiveEffectofValsartan[J].INTERNATIONALJOURNALOFHYPERTENSION,2022,2022. [ 3 ]Liu,Yi #;Chen,Zhehui(chenzhehui)#;Dong,Hui(donghui)#;Ding,Yuan;He,Ruxuan;Kang,Lulu;Li,Dongxiao;Shen,Ming;Jin,Ying;Zhang,Yao;Song,Jinqing;Tian,Yaping;Cao,YongTong *;Liang,Desheng(liangdesheng)*;Yang,Yanling(yangyanling)*.Analysisoftherelationshipbetweenphenotypesandgenotypesin60Chinesepatientswithpropionicacidemia:afourteen-yearexperienceatatertiaryhospital[J].ORPHANETJOURNALOFRAREDISEASES,2022,17(1). [ 4 ]Ma,Liang #;Gong,Jian;Zhao,MeiMei;Kong,XiaoMu;Gao,Peng;Jiang,YongWei;Liu,Yi;Feng,Xiaoyan;Si,Shuang *;Cao,YongTong *.ANovelStoolMethylationTestfortheNon-InvasiveScreeningofGastricandColorectalCancer[J].FRONTIERSINONCOLOGY,2022,12. [ 5 ]Ma,Liang #;Qin,Geng #;Gai,Fei;Jiang,YongWei;Huang,Zhan;Yang,Hui;Yao,ShuKun;Du,ShiYu *;Cao,YongTong *.Anovelmethodforearlydetectionofcolorectalcancerbasedondetectionofmethylationoftwofragmentsofsyndecan-2(SDC2)instoolDNA[J].BMCGASTROENTEROLOGY,2022,22(1). [ 6 ]Kong,XiaoMu #;Xu,Ye(xuye)#;Gao,Peng;Liu,Yi;Wang,Xuran;Zhao,MeiMei;Jiang,YongWei;Yang,Hui;Cao,YongTong *;Ma,Liang *.Rapiddetectionoftheirinotecan-relatedUGT1A128polymorphismbyasymmetricPCRmeltingcurveanalysisusingonefluorescentprobe[J].JOURNALOFCLINICALLABORATORYANALYSIS,2022,36(8). [ 7 ]Lu,HongKai #;Wang,Na #;Wang,Peng;Zhang,Haolin;Zhao,Ru;Liu,Hongju;He,XiRong;Liu,ZeYa;Chang,Yue;Cao,YongTong *;Wang,ShiYao *.Casereport:Firstcaseofpemetrexedpluscisplatin-inducedimmunehemolyticanemiainapatientwithlungadenocarcinoma[J].FRONTIERSINMEDICINE,2022,9. [ 8 ]Chen,LiDa #;Zheng,Chao;Hao,MengMeng;Gao,Peng;Zhao,MeiMei;Cao,YongTong *;Ma,Liang *.AssociationofABCC2polymorphismwithclopidogrelresponseinChinesepatientsundergoingpercutaneouscoronaryintervention[J].FRONTIERSINPHARMACOLOGY,2022,13. [ 9 ]Zhao,Wei #;Duan,Lei #;Fang,Long;Li,JingHua;Li,ShiRui;Wang,LiNa;Zhang,JingYing;Zhang,Wan;Cao,YongTong *.Persistentincreaseofcarbohydrateantigen19-9withanunknownreason:Aseven-yearfollow-upcase[J].JOURNALOFCLINICALLABORATORYANALYSIS,2022,36(12). [ 10 ] Zhou,Yun #;Wei,LiLong;Zhang,RuiPing;Han,ChengWu;Cao,YongTong *. GlobularadiponectininhibitsosteoblasticdifferentiationofvascularsmoothmusclecellsthroughthePI3K/AKTandWnt/beta-cateninpathway[J].JOURNALOFMOLECULARHISTOLOGY,2021,52(5):1067-1080.:.: 、 “ 、 ”.